Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Amgen Inc (AMGN)

Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 140,398,256
  • Shares Outstanding, K 537,533
  • Annual Sales, $ 28,190 M
  • Annual Income, $ 6,717 M
  • EBIT $ 6,218 M
  • EBITDA $ 10,289 M
  • 60-Month Beta 0.55
  • Price/Sales 4.93
  • Price/Cash Flow 9.82
  • Price/Book 18.48

Options Overview Details

View History
  • Implied Volatility 23.12% ( -3.86%)
  • Historical Volatility 32.62%
  • IV Percentile 48%
  • IV Rank 13.25%
  • IV High 55.92% on 11/20/24
  • IV Low 18.11% on 05/21/24
  • Put/Call Vol Ratio 0.90
  • Today's Volume 17,004
  • Volume Avg (30-Day) 24,349
  • Put/Call OI Ratio 0.72
  • Today's Open Interest 226,362
  • Open Int (30-Day) 223,958

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 30 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 4.97
  • Number of Estimates 12
  • High Estimate 5.27
  • Low Estimate 4.71
  • Prior Year 4.71
  • Growth Rate Est. (year over year) +5.52%

Price Performance

See More
Period Period Low Period High Performance
1-Month
253.30 +3.98%
on 12/19/24
297.32 -11.42%
on 11/25/24
-24.49 (-8.51%)
since 11/20/24
3-Month
253.30 +3.98%
on 12/19/24
339.17 -22.35%
on 09/23/24
-74.00 (-21.93%)
since 09/20/24
52-Week
253.30 +3.98%
on 12/19/24
346.85 -24.07%
on 07/25/24
-11.80 (-4.29%)
since 12/20/23

Most Recent Stories

More News
Novo Nordisk Heads For Worst Day In 22 Years As New Obesity Drug Underwhelms: Retail Brushes Off ‘Super Silly’ Drop

On the analyst front, Citi and UBS both described Novo’s readout as favorable for Eli Lilly.

VKTX : 42.25 (+1.83%)
NVO : 85.00 (-17.83%)
LLY : 767.76 (+1.35%)
AMGN : 263.38 (+0.84%)
Can Dow Jones ETF Reverse From the Worst Losing Streak in 50 Years?

The Dow Jones Industrial Average is experiencing its longest losing streak since 1978, falling for nine successive trading days. This marks a significant downturn, with the index dropping roughly 3%, or...

GOOG : 192.96 (+1.72%)
NVDA : 134.70 (+3.08%)
GOOGL : 191.41 (+1.54%)
AAPL : 254.49 (+1.88%)
AVGO : 220.79 (+1.13%)
JNJ : 144.47 (+0.62%)
AMGN : 263.38 (+0.84%)
UNH : 500.13 (+2.22%)
MSFT : 436.60 (-0.10%)
TSLA : 421.06 (-3.46%)
DIA : 428.54 (+1.24%)
AMZN : 224.92 (+0.73%)
Should You Scoop Up This 'Strong Buy' Biotech Before December 23?

Does this top-rated biotech stock deserve a spot in investors' portfolios before its Russell 2000 inclusion?

UPB : 16.21 (-2.41%)
REGN : 701.85 (-0.90%)
AMGN : 263.38 (+0.84%)
Dow on a Record Losing Streak: Should You Buy its ETF?

The Dow Jones Industrial Average has been on its worst losing streak in nearly 50 years as investors continued to rotate out of old economy names and pile into tech stocks and small-caps. The blue-chip...

NVDA : 134.70 (+3.08%)
JNJ : 144.47 (+0.62%)
AMGN : 263.38 (+0.84%)
DIA : 428.54 (+1.24%)
UNH : 500.13 (+2.22%)
These Are the 5 Worst-Performing Stocks in the Dow Jones Industrial Average With 2024 Almost Over

It's been a banner year for the stock market. However, not every stock has been a winner as some sectors performed better than others. Tech and utilities soared, while others like real estate and healthcare...

ALK : 66.02 (+1.62%)
MRK : 98.05 (-1.48%)
JNJ : 144.47 (+0.62%)
NKE : 76.94 (-0.21%)
$DOWI : 42,840.26 (+1.18%)
AMGN : 263.38 (+0.84%)
BA : 177.35 (+0.18%)
2 No-Brainer Dividend Stocks With Yields Over 3% to Buy in 2025 and Hold for a Decade or Longer

Whether you're looking for a way to beat the benchmark S&P 500 index or you just want a steady flow of passive income, dividend-paying stocks are a great way to achieve your investment goals.

KO : 62.55 (+0.16%)
AZN : 65.35 (+1.41%)
AMGN : 263.38 (+0.84%)
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?

Looking for reliable income in the stock market? You might want to consider the top Dogs of the Dow in December. Here's what you need to know about this trio of blue-chip stocks.

SHW : 345.47 (+0.90%)
VZ : 39.93 (-0.10%)
CVX : 142.85 (+1.20%)
INTC : 19.52 (+2.41%)
WBA : 9.55 (+2.14%)
$DOWI : 42,840.26 (+1.18%)
AMGN : 263.38 (+0.84%)
DIA : 428.54 (+1.24%)
MarketBeat Week in Review – 12/2 - 12/6

Equities continued their post-election rally after Friday’s solid November jobs report and all signs point to the rally in stocks extending into 2025

NFLX : 909.05 (+0.78%)
NVDA : 134.70 (+3.08%)
TSLA : 421.06 (-3.46%)
ULTA : 430.01 (+1.06%)
LYFT : 13.57 (-0.07%)
LLY : 767.76 (+1.35%)
RIVN : 13.83 (+5.90%)
RKLB : 24.87 (+7.11%)
UBER : 60.73 (+0.86%)
AMGN : 263.38 (+0.84%)
TSM : 197.21 (+1.32%)
CRM : 343.65 (+2.21%)
Amgen Stock Falls on Weight Loss Drug Data: Overreaction or Fair?

Results for Amgen's weight loss drug Maritide were highly anticipated, but fell short. However, MariTide could still turn the tables in future studies.

NVO : 85.00 (-17.83%)
LLY : 767.76 (+1.35%)
AMGN : 263.38 (+0.84%)
Is Regeneron Pharmaceuticals Stock Underperforming the Nasdaq?

Despite Regeneron Pharmaceuticals’ significant underperformance relative to Nasdaq recently, Wall Street analysts remain strongly optimistic about the stock’s prospects.

$NASX : 19,572.60 (+1.03%)
REGN : 701.85 (-0.90%)
AMGN : 263.38 (+0.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two...

See More

Key Turning Points

3rd Resistance Point 275.32
2nd Resistance Point 272.47
1st Resistance Point 267.92
Last Price 263.38
1st Support Level 260.52
2nd Support Level 257.67
3rd Support Level 253.12

See More

52-Week High 346.85
Fibonacci 61.8% 311.11
Fibonacci 50% 300.08
Fibonacci 38.2% 289.04
Last Price 263.38
52-Week Low 253.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar